6 things you need to know about Bladder Cancer | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Bladder cancer

June 2018

6 things you need to know about Bladder Cancer

  • Bladder cancer is the ninth most commonly diagnosed cancer in the world with an estimated 430 000 new cases reported in 2012.
  • Men are more than three times more likely to get bladder cancer than women.
  • Smoking is a major cause of bladder cancer.
  • Exposure to industrial chemicals such as metalworking fluids is another cause of bladder cancer.
  • One of the most common symptoms of bladder cancer is the presence of blood in urine.
  • Cystoscopy and urine cytology are the most common methods for detection and assessment of recurrence of bladder cancer. Cystoscopy may cause pain and discomfort in patients, and urine cytology has a low sensitivity.IDL Biotech has developed UBC Rapid, a complement to cystoscopy, which causes no pain for the patient. Read more about UBC Rapid here.

Meet IDL Biotech at Coalition against Typhoid Fever

Every two years, the Coalition against Typhoid, based at the Sabin Vaccine Institute (Sabin), convenes the International Conference on Typhoid and Other Invasive Salmonelloses. The 11th International Conference on Typhoid and Other Invasive Salmonelloses will be held from March 26-28, 2019 in Hanoi, Vietnam. IDL Biotech is proud to be a sponsor of this important conference.

Interview with CEO Charlotte Berg

Börshajen has published an interview with Charlotte Berg, CEO at IDL Biotech.

IDL Biotech

Skip this intro